Der Campus Berlin-Buch liegt im Berliner Ortsteil Buch im Bezirk Pankow und ist das Herzstück des Zukunftsorts Buch, einem der elf Berliner Zukunftsorte.

During the past decade, Robert Roessle Comprehensive Cancer Center - Charite Campus Buch conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robert Roessle Comprehensive Cancer Center - Charite Campus Buch" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "German CLL Study Group" with 1 trials sponsored, "Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen Krebsgesellschaft" with 1 trials sponsored and "Technical University of Munich" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Robert Roessle Comprehensive Cancer Center - Charite Campus Buch" are "Lymphoma" (2 trials), "Anal Cancer" (1 trials), "Gastrointestinal Stromal Tumor" (1 trials), "Pancreatic Cancer" (1 trials) and "T-Cell Large Granular Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Robert Roessle Comprehensive Cancer Center - Charite Campus Buch" in a lesser frequency.

Most popular intervention types in "Robert Roessle Comprehensive Cancer Center - Charite Campus Buch" are "Drug" (6 trials), "Radiation" (4 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "cisplatin" (2 trials), "conventional surgery" (2 trials), "cyclophosphamide" (2 trials) and "doxorubicin hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Robert Roessle Comprehensive Cancer Center - Charite Campus Buch" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Robert Roessle Comprehensive Cancer Center - Charite Campus Buch". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Robert Roessle Comprehensive Cancer Center - Charite Campus Buch, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Robert Roessle Comprehensive Cancer Center - Charite Campus Buch, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".